Clinical Trial: Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis

U.S., Dec. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07308392) titled 'Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis' on Dec. 15.

Brief Summary: Phase II clinical trial evaluating the efficacy and safety of HRS-7249 and SHR-1918 in patients with severe hypertriglyceridemia at high risk of acute pancreatitis

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Severe Hypertriglyceridemia With a High Risk of Acute Pancreatitis

Intervention: DRUG: HRS-7249 injection set

HRS-7249 injection set

DRUG: SHR-1918 injection set

SHR-1918 injection set

DRUG: HRS-7249 injecti...